Holen Sie sich die Stockscreener-App
0.3274
7.51%
-0.0266
Handel nachbörslich:
.32
-0.0074
-2.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.354
Offen:
$0.34
24-Stunden-Volumen:
12.57M
Relative Volume:
1.95
Marktkapitalisierung:
$13.60M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-0.5197
EPS:
-0.63
Netto-Cashflow:
$-13.77M
1W Leistung:
+3.44%
1M Leistung:
-22.69%
6M Leistung:
-3.71%
1J Leistung:
-86.74%
1-Tages-Spanne:
$0.305
$0.3711
1-Wochen-Bereich:
$0.2774
$0.443
52-Wochen-Spanne:
$0.2179
$3.00
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3274 | 14.71M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: ProPhase Labs Q2 2025 reveals EPS beat, stock drops - Investing.com
ProPhase Labs earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Achieves Key U.S. Patent for Test - TipRanks
ProPhase Labs Posts Narrower Q2 Loss - The Motley Fool
ProPhase Labs Posts Narrower Q2 Loss - Nasdaq
Can ProPhase Labs Inc. expand into new marketsJuly 2025 Macro Moves & Real-Time Volume Surge Alerts - newsyoung.net
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewswire
ProPhase Labs Schedules Q2 2025 Earnings Release and Conference Call - AInvest
Why did PRPH's Q4 2024 earnings surprise analysts? - AInvest
What caused PRPH's earnings to drop in Q3 2024? - AInvest
How did PRPH's 2024 earnings trend evolve? - AInvest
What does PRPH's earnings volatility indicate? - AInvest
ProPhase Labs Seeks Enhanced Shareholder Value through Reverse Merger and Bitcoin Integration - AInvest
ProPhase Labs (PRPH.O) Surges Over 33% — What’s Behind the Sharp Intraday Move? - AInvest
PRPH.O Surges 29.75%: Tracing the Source of the Sudden Intraday Spike - AInvest
ProPhase Labs Surges 23.75%: Patent Grant and Earnings Call Spark Volatility - AInvest
ProPhase Labs (PRPH) Surges 27.76% on Patent Approval and BE-Smart Validation—What’s Next for This Biotech Play? - AInvest
ProPhase Labs stock soars after securing patent for esophageal disease test By Investing.com - Investing.com South Africa
ProPhase Labs stock soars after securing patent for esophageal disease test - Investing.com
ProPhase Labs shares rise 35.82% premarket after receiving US patent for esophageal product. - AInvest
ProPhase Labs receives patent for Barrett’s esophagus testing technology - Investing.com
ProPhase Labs Announces Full USPTO Approval for Issuance of - GlobeNewswire
ProPhase Labs Secures Game-Changing Patent for Early Cancer Detection with 95% Accuracy Rate - Stock Titan
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 - GlobeNewswire
ProPhase Labs to present Q2 2025 financial results on virtual conference call. - AInvest
ProPhase Labs Earnings: Biotech Leader Sets Q2 Financial Results Presentation This Week - Stock Titan
ProPhase Labs PRPH 2025Q2 Earnings Preview Neutral Outlook Amid Uncertain Market Conditions - AInvest
Is ProPhase Labs Inc. vulnerable to short sellersElite Return Strategy Watch - thegnnews.com
Prophase Labs Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
ProPhase Labs Inc. Bounces Off Moving Average SupportLow Drawdown Real Time Trading Tips Shared - beatles.ru
ProPhase Labs Appoints New Fractional CFO - TipRanks
Sector ETF Data Correlates with Strength in ProPhase Labs Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Is This a Bottoming Phase for ProPhase Labs Inc.Confirmed Setup With Expert Accuracy Supported - beatles.ru
ProPhase Labs Inc. Rebound Backed by Sentiment ShiftInvestment Plan With Growth Optimization Finalized - metal.it
Why is ProPhase Labs Inc. stock attracting strong analyst attentionBreakneck growth rates - Jammu Links News
How does ProPhase Labs Inc. generate profit in a changing economyExceptional trading performance - Jammu Links News
Is ProPhase Labs Inc. a growth stock or a value stockMaximize your portfolio’s earning power - Jammu Links News
What makes ProPhase Labs Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Is ProPhase Labs Inc. a good long term investmentTrack high-yield stocks before they peak - Jammu Links News
What institutional investors are buying ProPhase Labs Inc. stockInvest confidently with data-driven strategies - Jammu Links News
Should I hold or sell ProPhase Labs Inc. stock in 2025Consistently profitable trades - Jammu Links News
How volatile is ProPhase Labs Inc. stock compared to the marketBuild a diversified portfolio for risk management - Jammu Links News
What drives ProPhase Labs Inc. stock priceOver 200% growth - Jammu Links News
What are analysts’ price targets for ProPhase Labs Inc. in the next 12 monthsBuild a winning investment strategy - Jammu Links News
How does ProPhase Labs Inc. compare to its industry peersExceptional earning trajectories - Jammu Links News
What catalysts could drive ProPhase Labs Inc. stock higher in 2025Market Forecast Updates That Work - Jammu Links News
What are ProPhase Labs Inc. company’s key revenue driversAI Powered Forecasts With Proven Results - jammulinksnews.com
ProPhase Labs Announces Shareholder Meeting to Increase Authorized Shares to 1 Billion, Targets $50 Million Covid Accounts Receivables Collection, and Advances BE-Smart Esophageal Cancer Test Development. - AInvest
ProPhase Labs shares rise 4.29% premarket after announcing a special meeting to increase authorized shares to 1 billion. - AInvest
Screener Results Flag ProPhase Labs Inc. as OversoldSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):